Mapping of the RXRα binding elements involved in retinoic acid induced transcriptional activation of the human SOX3 gene

Neuroscience Research

Volumn 56, Issue 4, 2006, Pages 409-418

  Mojsin, Marija ^a   Grujičić, Nataša Kovačević ^a   Nikčević, Gordana ^a   Krstić, Aleksandar ^a   Savić, Tijana ^a   Stevanović, Milena ^a  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

Author keywords

Neural development; NT2 D1 cell line; Retinoic acid; RXR ; SOX3 gene

Indexed keywords

RETINOIC ACID; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX3; UNCLASSIFIED DRUG; DEOXYRIBONUCLEASE I; DNA BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; EMBRYO; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE MAPPING; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MOLECULAR INTERACTION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ESCHERICHIA COLI; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN BINDING; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; DEOXYRIBONUCLEASE I; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESCHERICHIA COLI; GENES, REPORTER; HIGH MOBILITY GROUP PROTEINS; HUMANS; PROTEIN BINDING; RECOMBINANT PROTEINS; RETINOID X RECEPTOR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 33750969099     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.08.010     Document Type: Article

References (42)

1. Afonja O., Raaka B.M., Huang A., Das S., Zhao X., Helmer E., Juste D., and Samuels H.H. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene 21 51 (2002) 7850-7860
2. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103 2 (1984) 285-293
3. Andrews P.W. Human teratocarcinomas. Biochim. Biophys. Acta 948 1 (1988) 17-36
4. Boshart M., Kluppel M., Schmidt A., Schutz G., and Luckow B. Reporter constructs with low background activity utilizing the cat gene. Gene 110 1 (1992) 129-130
5. Brondani V., Klimkait T., Egly J.M., and Hamy F. Promoter of FGF8 reveals a unique regulation by unliganded RARalpha. J. Mol. Biol. 319 3 (2002) 715-728
6. Brunelli S., Silva Casey E., Bell D., Harland R., and Lovell-Badge R. Expression of Sox3 throughout the developing central nervous system is dependent on the combined action of discrete, evolutionarily conserved regulatory elements. Genesis 36 1 (2003) 12-24
7. Bylund M., Andersson E., Novitch B.G., and Muhr J. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat. Neurosci. 6 11 (2003) 1162-1168
8. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 9 (1996) 940-954
9. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 8 (1987) 2745-2752
10. Cheung W.M., Chu P.W., Lung C.H., and Ip N.Y. Expression of retinoid receptors during the retinoic acid-induced neuronal differentiation of human embryonal carcinoma cells. J. Neurochem. 75 1 (2000) 34-40
11. Djurovic J., and Stevanovic M. Structural and functional characterization of the human SOX14 promoter. Biochim. Biophys. Acta 1680 1 (2004) 53-59
12. Freemantle S.J., Kerley J.S., Olsen S.L., Gross R.H., and Spinella M.J. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21 18 (2002) 2880-2889
13. Hamada-Kanazawa M., Ishikawa K., Ogawa D., Kanai M., Kawai Y., Narahara M., and Miyake M. Suppression of Sox6 in P19 cells leads to failure of neuronal differentiation by retinoic acid and induces retinoic acid-dependent apoptosis. FEBS Lett. 577 1-2 (2004) 60-66
14. Harris L.R., Kamarainen O.P., Sevakivi M., Miller G.C., Clarke J.W., Potter J.L., and Bridgewater L.C. A novel retinoic acid-response element requires an enhancer element mediator for transcriptional activation. Biochem. J. 383 Pt 1 (2004) 37-43
15. Irrthum A., Devriendt K., Chitayat D., Matthijs G., Glade C., Steijlen P.M., Fryns J.P., Van Steensel M.A., and Vikkula M. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am. J. Hum. Genet. 72 6 (2003) 1470-1478
16. Kamachi Y., Uchikawa M., and Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16 4 (2000) 182-187
17. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?. Cell 83 6 (1995) 859-869
18. Kastner P., Mark M., Ghyselinck N., Krezel W., Dupe V., Grondona J.M., and Chambon P. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124 2 (1997) 313-326
19. Kato S., Sasaki H., Suzawa M., Masushige S., Tora L., Chambon P., and Gronemeyer H. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol. Cell. Biol. 15 11 (1995) 5858-5867
20. Kovacevic Grujicic N., Mojsin M., Krstic A., and Stevanovic M. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity. Gene 344 (2005) 287-297
21. Laudet V., and Gronemeyer H. The Nuclear Receptor Factsbook (2002), Academic Press, San Diego, CA pp. 462
22. Laumonnier F., Ronce N., Hamel B.C., Thomas P., Lespinasse J., Raynaud M., Paringaux C., Van Bokhoven H., Kalscheuer V., Fryns J.P., Chelly J., Moraine C., and Briault S. Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am. J. Hum. Genet. 71 6 (2002) 1450-1455
23. Lee V.M., and Andrews P.W. Differentiation of NTERA-2 clonal human embryonal carcinoma cells into neurons involves the induction of all three neurofilament proteins. J. Neurosci. 6 2 (1986) 514-521
24. Mangelsdorf D.J., Ong E.S., Dyck J.A., and Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345 6272 (1990) 224-229
25. Mangelsdorf D.J., Umesono K., Kliewer S.A., Borgmeyer U., Ong E.S., and Evans R.M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66 3 (1991) 555-561
26. Murakami A., Shen H., Ishida S., and Dickson C. SOX7 and GATA-4 are competitive activators of Fgf-3 transcription. J. Biol. Chem. 279 27 (2004) 28564-28573
27. Panariello L., Quadro L., Trematerra S., and Colantuoni V. Identification of a novel retinoic acid response element in the promoter region of the retinol-binding protein gene. J. Biol. Chem. 271 41 (1996) 25524-25532
28. Pevny L.H., and Lovell-Badge R. Sox genes find their feet. Curr. Opin. Genet. Dev. 7 3 (1997) 338-344
29. Redfern C.P. Enhancing enhancers: new complexities in the retinoid regulation of gene expression. Biochem. J. 383 Pt 1 (2004) e1-e2
30. Roberts A.B., and Sporn M.B. Cellular biology and biochemistry of the retinoids. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The Retinoids vol. 2 (1984), Academic Press, Orlando 209-286
31. Saitoh T., and Katoh M. Expression of human SOX18 in normal tissues and tumors. Int. J. Mol. Med. 10 3 (2002) 339-344
32. Sekiya I., Koopman P., Tsuji K., Mertin S., Harley V., Yamada Y., Shinomiya K., Niguji A., and Noda M. Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid. J. Cell Biochem. Suppl. 36 Suppl. (2001) 71-78
33. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., Nifuji A., and Noda M. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275 15 (2000) 10738-10744
34. Solomon N.M., Nouri S., Warne G.L., Lagerstrom-Fermer M., Forrest S.M., and Thomas P.Q. Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics 79 4 (2002) 553-559
35. Spinella M.J., Kerley J.S., White K.A., and Curtin J.C. Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model. J. Nutr. 133 1 (2003) 273S-276S
36. Stevanovic M. Modulation of SOX2 and SOX3 gene expression during differentiation of human neuronal precursor cell line NTERA2. Mol. Biol. Rep. 30 2 (2003) 127-132
37. Stevanovic M., Lovell-Badge R., Collignon J., and Goodfellow P.N. SOX3 is an X-linked gene related to SRY. Hum. Mol. Genet. 2 12 (1993) 2013-2018
38. Wang J., and Yen A. A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression. Mol. Cell. Biol. 24 6 (2004) 2423-2443
39. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27 6 (1999) 1409-1420
40. Weston A.D., Chandraratna R.A., Torchia J., and Underhill T.M. Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. J. Cell Biol. 158 1 (2002) 39-51
41. Wiebe M.S., Wilder P.J., Kelly D., and Rizzino A. Isolation, characterization, and differential expression of the murine Sox-2 promoter. Gene 246 1-2 (2000) 383-393
42. Wood H.B., and Episkopou V. Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech. Dev. 86 1-2 (1999) 197-201